Most read article(s)

Open Access
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
R. L. Carhart-Harris and K. J. Friston
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2019, 71 (3) 316-344; DOI: https://doi.org/10.1124/pr.118.017160
You have access
Psychedelics
David E. Nichols
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews April 2016, 68 (2) 264-355; DOI: https://doi.org/10.1124/pr.115.011478
Open Access
Subcellular Organization of the cAMP Signaling Pathway
Manuela Zaccolo, Anna Zerio and Miguel J. Lobo
Christopher Garland, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 278-309; DOI: https://doi.org/10.1124/pharmrev.120.000086
Open Access
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Ai-Ming Yu, Young Hee Choi and Mei-Juan Tu
RHIAN M. TOUYZ, ASSOCIATE EDITOR

Pharmacological Reviews October 2020, 72 (4) 862-898; DOI: https://doi.org/10.1124/pr.120.019554
You have access
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Astrid Nehlig
Stephen P. H. Alexander, ASSOCIATE EDITOR

Pharmacological Reviews April 2018, 70 (2) 384-411; DOI: https://doi.org/10.1124/pr.117.014407
Open Access
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner and Tom E. Mollnes
Finn Olav Levy, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 792-827; DOI: https://doi.org/10.1124/pharmrev.120.000072
Open Access
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio and Gabriella Gobbi
Michael Nader, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 202-277; DOI: https://doi.org/10.1124/pharmrev.120.000056
Open Access
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species
B. D. van Groen, J. Nicolaï, A. C. Kuik, S. Van Cruchten, E. van Peer, A. Smits, S. Schmidt, S. N. de Wildt, K. Allegaert, L. De Schaepdrijver, P. Annaert and J. Badée
Hyunyoung Jeong, ASSOCIATE EDITOR

Pharmacological Reviews April 2021, 73 (2) 597-678; DOI: https://doi.org/10.1124/pharmrev.120.000071
Open Access
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya and Annamaria Vezzani
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2020, 72 (3) 606-638; DOI: https://doi.org/10.1124/pr.120.019539
You have access
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts and Daniel Hoyer
Eliot H. Ohlstein, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 310-520; DOI: https://doi.org/10.1124/pr.118.015552

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals